Insider acquisitions

Explore purchases, stock awards, gifts, exercises, and conversions. These records cover acquisitions only; sales are not included.

Reset
Form 4, 4/A, 5 & 5/AAmounts retain the reported currency, when available.

Transaction timeline & trade size

Choose a reporting owner, transaction period, and security. Open any point for the filing.

Purchases in this page3
Other acquisitions47
Reporting owners48
Sales (not included)Not included in this datasetCheck original SEC filings

Aug 18, 2025 – Oct 21, 2025 · Transaction dates · Current page sample

Reported transaction sizes · security units

MBX Biosciences, Inc. · Common Stock · Purchase (code P) · Non-derivative · Not reported

Reported transaction sizes by transaction date.Each point is one transaction for the selected company, security, and acquisition type. Reporting owners, exact quantities, and values are also provided in the table. These are filing amounts, not a stock-price series.20,0000MBX Biosciences, Inc. · Hawryluk P. Kent (President & CEO · Director) · Purchase · October 20, 2025 · Quantity 20,000 · Price 13.6395 · Reference value 272,790 · Not reportedAug 18, 2025Oct 21, 2025No reported values to plot for this selection.

Swipe the chart to see the full date range. Exact records are available in the table below.

1 transaction plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

50 dated transactions in this page sample · 48 reporting owners.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition typeQuantityPriceReference valueCurrency
Oct 20, 2025MBX Biosciences, Inc.Common StockHawryluk P. Kent (President & CEO · Director)Purchase20,00013.6395272,790Not reported
Oct 20, 2025TransDigm Group INCCommon StockReiss Joel (Co-Chief Operating Officer)Exercise / conversion3,000284.97854,910Not reported
Oct 20, 2025Corbus Pharmaceuticals Holdings, Inc.Common Stock, par value $0.0001 per shareAltmeyer Anne (Director)Exercise / conversion1,0604.85,088Not reported
Oct 20, 2025CSX CORPCommon StockANGEL STEPHEN F (President & CEO · Director)Purchase55,00036.872,027,850Not reported
Oct 21, 2025PROSPERITY BANCSHARES INCCommon StockDavenport J. Mays (EVP/Director of Corp Strategy)Stock award10,00000Not reported
Oct 21, 2025PROSPERITY BANCSHARES INCCommon StockHanigan Kevin J (President & COO · Director)Stock award30,00000Not reported
Oct 19, 2025Vivid Seats Inc.Class A Common StockDixon Craig A. (Director)Exercise / conversion245Not reportedNot reportedNot reported
Oct 19, 2025Vivid Seats Inc.Class A Common StockBoehly Todd L (Director · 10% owner)Exercise / conversion245Not reportedNot reportedNot reported
Oct 19, 2025Vivid Seats Inc.Class A Common StockANDERSON MARK M. (Director)Exercise / conversion245Not reportedNot reportedNot reported
Oct 19, 2025Vivid Seats Inc.Class A Common StockBakal Riva (Chief Supply/Customer Officer)Exercise / conversion193Not reportedNot reportedNot reported
Oct 19, 2025Vivid Seats Inc.Class A Common StockMasino Julie D. (Director)Exercise / conversion245Not reportedNot reportedNot reported
Oct 19, 2025Vivid Seats Inc.Class A Common StockDonnini David (Director)Exercise / conversion245Not reportedNot reportedNot reported
Oct 19, 2025Vivid Seats Inc.Class A Common StockPickus Edward (Chief Accounting Officer)Exercise / conversion91Not reportedNot reportedNot reported
Oct 19, 2025Vivid Seats Inc.Class A Common StockFey Lawrence (Chief Financial Officer)Exercise / conversion625Not reportedNot reportedNot reported
Oct 19, 2025Vivid Seats Inc.Class A Common StockChia Stanley (Chief Executive Officer · Director)Exercise / conversion782Not reportedNot reportedNot reported
Oct 19, 2025Vivid Seats Inc.Class A Common StockDeFlorio Jane E. (Director)Exercise / conversion245Not reportedNot reportedNot reported
Oct 14, 2025ATOSSA THERAPEUTICS, INC.Stock Option (right to buy)Daniel Mark James (Chief Financial Officer)Stock award578,00000Not reported
Oct 20, 2025FATE THERAPEUTICS INCStock Option (Right to Buy)Adawi Kamal (Chief Financial Officer)Stock award375,00000Not reported
Oct 20, 2025FATE THERAPEUTICS INCCommon StockAdawi Kamal (Chief Financial Officer)Stock award75,00000Not reported
Oct 18, 2025Solid Biosciences Inc.Common StockBrooks Gabriel (Chief Medical Officer)Exercise / conversion9,750Not reportedNot reportedNot reported
Oct 17, 2025AGENUS INCCommon StockARMEN GARO H (See Remarks · Director)Stock award4,2163.8816,358.08Not reported
Oct 17, 2025Sphere Entertainment Co.Restricted Stock UnitsDolan Ryan Thomas (Director)Stock award71600Not reported
Oct 19, 2025HERON THERAPEUTICS, INC. /DE/Common StockForbes William P (EVP, Chief Development Officer)Exercise / conversion3,874Not reportedNot reportedNot reported
Oct 19, 2025HERON THERAPEUTICS, INC. /DE/Common StockDuarte Ira (EVP, Chief Financial Officer)Exercise / conversion3,874Not reportedNot reportedNot reported
Oct 19, 2025HERON THERAPEUTICS, INC. /DE/Common StockCollard Craig A (Chief Executive Officer · Director)Exercise / conversion13,797Not reportedNot reportedNot reported
Oct 17, 2025IGC Pharma, Inc.OptionsMoran James P (Director)Stock award500,00000Not reported
Oct 17, 2025IGC Pharma, Inc.OptionsLIERMAN TERRY L (Director)Stock award500,00000Not reported
Oct 17, 2025IGC Pharma, Inc.OptionsGRIMALDI CLAUDIA (PFO · Director)Stock award500,00000Not reported
Oct 17, 2025IGC Pharma, Inc.OptionsGRIMALDI CLAUDIA (PFO · Director)Stock award1,000,00000Not reported
Oct 17, 2025SCYNEXIS INCCommon StockAngulo Gonzalez David (Chief Executive Officer · Director)Stock award32,5000.7624,700Not reported
Oct 1, 2025NABORS INDUSTRIES LTDCommon StockRodriguez Rodriguez Miguel Angel (CHIEF FINANCIAL OFFICER)Stock award4,80700Not reported
Oct 19, 2025Seagate Technology Holdings plcOrdinary SharesArumugavelu Shankar (Director)Exercise / conversion2,69300Not reported
Oct 19, 2025Seagate Technology Holdings plcOrdinary SharesBRUNER JUDY (Director)Exercise / conversion2,69300Not reported
Oct 19, 2025Seagate Technology Holdings plcOrdinary SharesCANNON MICHAEL R (Director)Exercise / conversion3,42700Not reported
Oct 19, 2025Seagate Technology Holdings plcOrdinary SharesBHATT PRAT (Director)Exercise / conversion2,69300Not reported
Oct 19, 2025Seagate Technology Holdings plcOrdinary SharesHaggart Dylan G. (Director)Exercise / conversion2,69300Not reported
Oct 19, 2025Seagate Technology Holdings plcOrdinary SharesTilenius Stephanie (Director)Exercise / conversion2,69300Not reported
Oct 19, 2025Seagate Technology Holdings plcOrdinary SharesCLEMMER RICHARD L (Director)Exercise / conversion2,69300Not reported
Oct 19, 2025Seagate Technology Holdings plcOrdinary SharesConyers Yolanda Lee (Director)Exercise / conversion2,69300Not reported
Oct 19, 2025Seagate Technology Holdings plcOrdinary SharesGeldmacher Jay L (Director)Exercise / conversion2,69300Not reported
Oct 19, 2025Seagate Technology Holdings plcOrdinary SharesAdams Mark (Director)Exercise / conversion2,69300Not reported
Oct 20, 2025AMERICAN PUBLIC EDUCATION INCCommon Stock, par value $.01Codispoti Edward H (EVP & Chief Financial Officer)Stock award8,47700Not reported
Oct 20, 2025Salesforce, Inc.Common StockBenioff Marc (Chair and CEO · Director)Exercise / conversion2,250161.5363,375Not reported
Oct 21, 2025PHIBRO ANIMAL HEALTH CORPClass A Common StockBENDHEIM JACK (President and CEO · Director · 10% owner) · BFI Co., LLC (10% owner)Conversion50,00000Not reported
Oct 18, 2025BlueLinx Holdings Inc.Common StockDeBrock Kimberly Ann (VP & Chief Accounting Officer)Exercise / conversion232Not reportedNot reportedNot reported
Oct 21, 2025CYTOKINETICS INCCommon StockMalik Fady Ibraham (EVP Research & Development)Exercise / conversion2,10510.622,313Not reported
Oct 15, 2025CYTOKINETICS INCCommon StockWIERENGA WENDELL (Director)Stock award9962.86,217.2Not reported
Oct 17, 2025EAGLE CAPITAL GROWTH FUND, INC.Common StockSIMS LUKE E (President & CEO · Director)Purchase2,00010.7521,500Not reported
Aug 18, 2025EAGLE CAPITAL GROWTH FUND, INC.Common StockSIMS LUKE E (President & CEO · Director)Other acquisition97510.119,857.25Not reported
Oct 17, 2025NRC HEALTHDirector Stock Option (Right to Buy)NUNNELLY JOHN N (Director)Stock award22,62500Not reported

Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transaction details

Reporting owners, quantities, prices, and source filings.

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Transacted: MBX Biosciences, Inc.MBX · company listings
Hawryluk P. KentPresident & CEO · Director
PurchaseCommon StockNon-derivative security · Code P20,00013.6395 *Value: 272,790Not reportedView ↗
Transacted: TransDigm Group INCTDG · company listings
Reiss JoelCo-Chief Operating Officer
Exercise / conversionCommon StockNon-derivative security · Code M3,000284.97Value: 854,910Not reportedView ↗
Transacted: Corbus Pharmaceuticals Holdings, Inc.CRBP · company listingsExercise / conversionCommon Stock, par value $0.0001 per shareNon-derivative security · Code M1,0604.8Value: 5,088Not reportedView ↗
Transacted: CSX CORPCSX · company listings
ANGEL STEPHEN FPresident & CEO · Director
PurchaseCommon StockNon-derivative security · Code P55,00036.87 *Value: 2,027,850Not reportedView ↗
Transacted: PROSPERITY BANCSHARES INCPB · company listings
Davenport J. MaysEVP/Director of Corp Strategy
Stock awardCommon StockNon-derivative security · Code A10,0000Value: 0Not reportedView ↗
Transacted: PROSPERITY BANCSHARES INCPB · company listings
Hanigan Kevin JPresident & COO · Director
Stock awardCommon StockNon-derivative security · Code A30,0000Value: 0Not reportedView ↗
Transacted: Vivid Seats Inc.SEAT · company listingsExercise / conversionClass A Common StockNon-derivative security · Code M245Not reported *Value: Not reportedNot reportedView ↗
Transacted: Vivid Seats Inc.SEAT · company listings
Boehly Todd LDirector · 10% owner
Exercise / conversionClass A Common StockNon-derivative security · Code M245Not reported *Value: Not reportedNot reportedView ↗
Transacted: Vivid Seats Inc.SEAT · company listingsExercise / conversionClass A Common StockNon-derivative security · Code M245Not reported *Value: Not reportedNot reportedView ↗
Transacted: Vivid Seats Inc.SEAT · company listings
Bakal RivaChief Supply/Customer Officer
Exercise / conversionClass A Common StockNon-derivative security · Code M193Not reported *Value: Not reportedNot reportedView ↗
Transacted: Vivid Seats Inc.SEAT · company listingsExercise / conversionClass A Common StockNon-derivative security · Code M245Not reported *Value: Not reportedNot reportedView ↗
Transacted: Vivid Seats Inc.SEAT · company listingsExercise / conversionClass A Common StockNon-derivative security · Code M245Not reported *Value: Not reportedNot reportedView ↗
Transacted: Vivid Seats Inc.SEAT · company listings
Pickus EdwardChief Accounting Officer
Exercise / conversionClass A Common StockNon-derivative security · Code M91Not reported *Value: Not reportedNot reportedView ↗
Transacted: Vivid Seats Inc.SEAT · company listings
Fey LawrenceChief Financial Officer
Exercise / conversionClass A Common StockNon-derivative security · Code M625Not reported *Value: Not reportedNot reportedView ↗
Transacted: Vivid Seats Inc.SEAT · company listings
Chia StanleyChief Executive Officer · Director
Exercise / conversionClass A Common StockNon-derivative security · Code M782Not reported *Value: Not reportedNot reportedView ↗
Transacted: Vivid Seats Inc.SEAT · company listingsExercise / conversionClass A Common StockNon-derivative security · Code M245Not reported *Value: Not reportedNot reportedView ↗
Transacted: ATOSSA THERAPEUTICS, INC.ATOS · company listings
Daniel Mark JamesChief Financial Officer
Stock awardStock Option (right to buy)Derivative security · Code A578,0000Value: 0Not reportedView ↗
Transacted: FATE THERAPEUTICS INCFATE · company listings
Adawi KamalChief Financial Officer
Stock awardStock Option (Right to Buy)Derivative security · Code A375,0000Value: 0Not reportedView ↗
Transacted: FATE THERAPEUTICS INCFATE · company listings
Adawi KamalChief Financial Officer
Stock awardCommon StockNon-derivative security · Code A75,0000Value: 0Not reportedView ↗
Transacted: Solid Biosciences Inc.SLDB · company listings
Brooks GabrielChief Medical Officer
Exercise / conversionCommon StockNon-derivative security · Code M9,750Not reported *Value: Not reportedNot reportedView ↗
Transacted: AGENUS INCAGEN · company listings
ARMEN GARO HSee Remarks · Director
Stock awardCommon StockNon-derivative security · Code A4,2163.88 *Value: 16,358.08Not reportedView ↗
Transacted: Sphere Entertainment Co.SPHR · company listingsStock awardRestricted Stock UnitsDerivative security · Code A7160Value: 0Not reportedView ↗
Transacted: HERON THERAPEUTICS, INC. /DE/HRTX · company listings
Forbes William PEVP, Chief Development Officer
Exercise / conversionCommon StockNon-derivative security · Code M3,874Not reported *Value: Not reportedNot reportedView ↗
Transacted: HERON THERAPEUTICS, INC. /DE/HRTX · company listings
Duarte IraEVP, Chief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M3,874Not reported *Value: Not reportedNot reportedView ↗
Transacted: HERON THERAPEUTICS, INC. /DE/HRTX · company listings
Collard Craig AChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M13,797Not reported *Value: Not reportedNot reportedView ↗
Transacted: IGC Pharma, Inc.IGC · company listingsStock awardOptionsDerivative security · Code A500,0000Value: 0Not reportedView ↗
Transacted: IGC Pharma, Inc.IGC · company listingsStock awardOptionsDerivative security · Code A500,0000Value: 0Not reportedView ↗
Transacted: IGC Pharma, Inc.IGC · company listings
GRIMALDI CLAUDIAPFO · Director
Stock awardOptionsDerivative security · Code A500,0000Value: 0Not reportedView ↗
Transacted: IGC Pharma, Inc.IGC · company listings
GRIMALDI CLAUDIAPFO · Director
Stock awardOptionsDerivative security · Code A1,000,0000Value: 0Not reportedView ↗
Transacted: SCYNEXIS INCSCYX · company listings
Angulo Gonzalez DavidChief Executive Officer · Director
Stock awardCommon StockNon-derivative security · Code A32,5000.76Value: 24,700Not reportedView ↗
Transacted: NABORS INDUSTRIES LTDNBR · company listings
Rodriguez Rodriguez Miguel AngelCHIEF FINANCIAL OFFICER
Stock awardCommon StockNon-derivative security · Code A4,8070Value: 0Not reportedView ↗
Transacted: Seagate Technology Holdings plcSTX · company listingsExercise / conversionOrdinary SharesNon-derivative security · Code M2,6930Value: 0Not reportedView ↗
Transacted: Seagate Technology Holdings plcSTX · company listings
BRUNER JUDYDirector
Exercise / conversionOrdinary SharesNon-derivative security · Code M2,6930Value: 0Not reportedView ↗
Transacted: Seagate Technology Holdings plcSTX · company listingsExercise / conversionOrdinary SharesNon-derivative security · Code M3,4270Value: 0Not reportedView ↗
Transacted: Seagate Technology Holdings plcSTX · company listings
BHATT PRATDirector
Exercise / conversionOrdinary SharesNon-derivative security · Code M2,6930Value: 0Not reportedView ↗
Transacted: Seagate Technology Holdings plcSTX · company listingsExercise / conversionOrdinary SharesNon-derivative security · Code M2,6930Value: 0Not reportedView ↗
Transacted: Seagate Technology Holdings plcSTX · company listingsExercise / conversionOrdinary SharesNon-derivative security · Code M2,6930Value: 0Not reportedView ↗
Transacted: Seagate Technology Holdings plcSTX · company listingsExercise / conversionOrdinary SharesNon-derivative security · Code M2,6930Value: 0Not reportedView ↗
Transacted: Seagate Technology Holdings plcSTX · company listingsExercise / conversionOrdinary SharesNon-derivative security · Code M2,6930Value: 0Not reportedView ↗
Transacted: Seagate Technology Holdings plcSTX · company listingsExercise / conversionOrdinary SharesNon-derivative security · Code M2,6930Value: 0Not reportedView ↗
Transacted: Seagate Technology Holdings plcSTX · company listings
Adams MarkDirector
Exercise / conversionOrdinary SharesNon-derivative security · Code M2,6930Value: 0Not reportedView ↗
Transacted: AMERICAN PUBLIC EDUCATION INCAPEI · company listings
Codispoti Edward HEVP & Chief Financial Officer
Stock awardCommon Stock, par value $.01Non-derivative security · Code A8,4770Value: 0Not reportedView ↗
Transacted: Salesforce, Inc.CRM · company listings
Benioff MarcChair and CEO · Director
Exercise / conversionCommon StockNon-derivative security · Code M2,250161.5Value: 363,375Not reportedView ↗
Transacted: PHIBRO ANIMAL HEALTH CORPPAHC · company listings
BENDHEIM JACKPresident and CEO · Director · 10% owner
BFI Co., LLC10% owner
Joint filing · amounts unallocated
ConversionClass A Common StockNon-derivative security · Code C50,0000Value: 0Not reportedView ↗
Transacted: BlueLinx Holdings Inc.BXC · company listings
DeBrock Kimberly AnnVP & Chief Accounting Officer
Exercise / conversionCommon StockNon-derivative security · Code M232Not reported *Value: Not reportedNot reportedView ↗
Transacted: CYTOKINETICS INCCYTK · company listings
Malik Fady IbrahamEVP Research & Development
Exercise / conversionCommon StockNon-derivative security · Code M2,10510.6Value: 22,313Not reportedView ↗
Transacted: CYTOKINETICS INCCYTK · company listingsStock awardCommon StockNon-derivative security · Code A9962.8Value: 6,217.2Not reportedView ↗
Transacted: EAGLE CAPITAL GROWTH FUND, INC.GRF · company listings
SIMS LUKE EPresident & CEO · Director
PurchaseCommon StockNon-derivative security · Code P2,00010.75Value: 21,500Not reportedView ↗
Transacted: EAGLE CAPITAL GROWTH FUND, INC.GRF · company listings
SIMS LUKE EPresident & CEO · Director
Other acquisitionCommon StockNon-derivative security · Code L97510.11Value: 9,857.25Not reportedView ↗
Transacted: NRC HEALTHNRC · company listingsStock awardDirector Stock Option (Right to Buy)Derivative security · Code A22,6250Value: 0Not reportedView ↗

Filters use the date a filing was submitted, not the date of the transaction. Coverage is incomplete while historical records are being loaded. How we organize the data →